| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Aug―08 |
Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension |
Ryo Ohashi, Ryosuke Watari, Daisuke Kondo, Shuichi Otake, Tatsuhiko Murata, Go Kimura |
| 2 |
[GO] |
2024―Jun―11 |
<i>In vitro and in silico</i> study of new biscoumarin glycosides from <i>Paramignya trimera</i> against Angiotensin-converting enzyme 2 (ACE-2) for preventing SARS-CoV-2 infection |
Nguyen Xuan Ha, Tran Thu Huong, Pham Ngoc Khanh, Nguyen Phi Hung, Vu Thanh Loc, Vu Thi Ha, Dang Thu Quynh, Do Huu Nghi, Pham-The Hai, Christopher J. Scarlett, Ludger A. Wessjohann, Nguyen Manh Cuong |
| 3 |
[GO] |
2023―Nov―30 |
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement |
Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Kenichi Yamamoto, Soshi Nishimura, Shin-ichiro Hattori, Haydar Bulut, Hiroaki Mitsuya, Hirokazu Tamamura |
| 4 |
[GO] |
2023―Nov―30 |
<i>In Silico</i> Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease |
Kazunori Miwa, Yan Guo, Masayuki Hata, Yoshinori Hirano, Norio Yamamoto, Tyuji Hoshino |
| 5 |
[GO] |
2023―Apr―30 |
Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals |
Kazunori Miwa, Yan Guo, Masayuki Hata, Norio Yamamoto, Tyuji Hoshino |
| 6 |
[GO] |
2022―Sep―30 |
Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties |
Shiki Saito, Hirofumi Ohashi, Kou Nakamura, Junichiro Otagaki, Kazane Nishioka, Kota Nishiuchi, Ayaka Nakamura, Yukine Tsurukawa, Hisanobu Shibasaki, Hironobu Murakami, Masaki Nagane, Maiko Okada, Kouji Kuramochi, Koichi Watashi, Shinji Kamisuki |
| 7 |
[GO] |
2021―Dec―24 |
In vitro and in silico studies of potential coronavirus-specific 3C-like protease inhibitors |
Shoji Maehara, Manami Kobayashi, Mari Kuwada, Tominari Choshi, Hirohumi Inoue, Yuzou Hieda, Takashi Nishiyama, Toshiyuki Hata |
| 8 |
[GO] |
2021―Dec―20 |
Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors |
Tsukasa Hasegawa, Riyo M. Imamura, Tateki Suzuki, Takao Hashiguchi, Takao Nomura, Satoko Otsuguro, Katsumi Maenaka, Michihito Sasaki, Yasuko Orba, Hirofumi Sawa, Akihiko Sato, Takayoshi Okabe, Tetsuo Nagano, Hirotatsu Kojima |
| 9 |
[GO] |
2021―Feb―28 |
Impact of COVID-19 Outbreak on the Long-Range Transport of Common Air Pollutants in KUWAMS |
Hao Zhang, Lulu Zhang, Lu Yang, Quanyu Zhou, Xuan Zhang, Wanli Xing, Kazuichi Hayakawa, Akira Toriba, Ning Tang |
|
